نتایج جستجو برای: meningococcal meningitis
تعداد نتایج: 22329 فیلتر نتایج به سال:
Introduction Meningococcal disease remains an important public health problem worldwide due to its high lethality and high sequelae rates. Although meningococcal disease shows a decreasing incidence trend, vaccination against the current predominant serogroup (serogroup B) in Europe is not offered by routine in Spain and continuous surveillance is needed. Methods Meningococcal disease (ICD-9: 0...
BACKGROUND The Kassena-Nankana District of northern Ghana lies in the African "meningitis belt" where epidemics of meningococcal meningitis have been reoccurring every eight to 12 years for the last 100 years. The dynamics of meningococcal colonisation and disease are incompletely understood, and hence we embarked on a long-term study to determine how levels of colonisation with different bacte...
Neisseria meningitidis accounted for over half the 2,360 notified cases of meningitis in England and Wales in 19971 and is the leading infectious cause of death in childhood2–4. There were twice as many notifications of meningococcal disease in 1997 as in 1994 and the mortality remained at around 10% (ca 240 deaths)1,2. This article focuses on the presentation and management of meningococcal di...
Adults without neurologic sequelae after bacterial meningitis are supposed to live without restrictions. Neuropsychological outcome was assessed in 51 adults from a prospective cohort with good recovery, defined as Glasgow Outcome Scale score 5, after pneumococcal or meningococcal meningitis. Patients who recovered well after pneumococcal meningitis showed cognitive slowness (P=.001). A cogniti...
BACKGROUND A serogroup A meningococcal polysaccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safety and immunogenicity. This vaccine is now being deployed across the African meningitis belt. We studied the effect of PsA-TT on meningococcal meningitis and carriage in Chad during a serogroup A meni...
Meningococcal meningitis is a public health problem. The aim of this study was to describe the clinical characteristics of patients with meningococcal meningitis, and to identify associated factors with mortality. This was a retrospective study, between 2006 and 2011, at a referral center in São Paulo, Brazil. Logistic regression analysis was used to identify factors associated with mortality. ...
Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis 8 is a public health burden to both developed and developing countries throughout the world. There 9 are a number of vaccines (polysaccharide-based, glycoconjugate, protein-based and combined 10 conjugate vaccines) that are approved to target five of the six disease-causing serogroups of the 11 pathogen. ...
Meningococcal meningitis and septicaemia remain a serious global health threat. This review focuses on the epidemiology of meningococcal disease following the recent implementation of effective vaccines and the potential utility of a vaccine against serogroup B meningococcus.
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید